title: [Comparative metabonomics study on urine in rat treated by Angelica sinensis volatile oil].
abstract: Metabonomics was employed to investigate the effect of Angelica sinensis volatile oil (ASVO) to the endogenous metabolites of normal rats, and to reveal the possible ways of metabolism in rats caused by ASVO. The fifty male Waster rats were randomly divided into five groups (each consists of 10 rats), such as control group, high dose group of ASVO, middle dose group of ASVO, low dose group of ASVO, and Aspirin group. They were given 0.9% saline, 0.352 mL x kg(-1) ASVO, 0.176 mL x kg(-1) ASVO, 0.088 mL x kg(-1) ASVO and ASP respectively with the equal volume of 0.2 mL. Drugs and vehicle were given for 3 successive days. The urine was collected at 12, 24, 36, 48 h after modeling with metabolic cages. Rat urine metabolic fingerprint in different stages was analyzed using GC-MS, based on which the principal component analysis (PCA)and orthogonal partial least-squares discriminant analysis (OPLS-DA) models were established for metabonomic analysis. Potential biomarkers were screened by using variable importance in the projection (VIP) and T test. It was revealed that the middle dose of ASVO at 36 h induces a substantial change in rat urine. Compared with control group, seven kinds of endogenous metabolites in ASP group and ASVO group change significantly (P < 0.05), among which aconitic acid, succinic acid, citric acid, alpha-ketone glutaric acid, glycine and malic acid content had an upward trend (P < 0.05) and prostaglandin content had a downward trend (P < 0.01). The mechanism of ASVO and ASP have the similarity. It is likely that ASVO intervenes the metabolic process by affecting the energy, amino acid and lipid metabolism. Our work also indicates that rats administrated with ASVO can increase the energy metabolism of the body, induce the production of inflammatory substances and strengthen the body's immune ability. The result has also provide a proof for futher interpret ASVO pharmacological effects.
authors.forename: Jin-Xia
authors.initials: JX
authors.lastname: Li
authors.forename: Man
authors.initials: M
authors.lastname: Zhang
authors.forename: Li-Bo
authors.initials: LB
authors.lastname: Sun
authors.forename: Ling
authors.initials: L
authors.lastname: Zhang
authors.forename: Wen-Quan
authors.initials: WQ
authors.lastname: Zhang
authors.forename: Hai-Fu
authors.initials: HF
authors.lastname: Zhao
authors.forename: Peng-Ling
authors.initials: PL
authors.lastname: Li
authors.forename: Yong-Li
authors.initials: YL
authors.lastname: Hua
authors.forename: Peng
authors.initials: P
authors.lastname: Ji
authors.forename: Yan-Ming
authors.initials: YM
authors.lastname: Wei
mesh_terms: D029971:Angelica sinensis / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D055432:Metabolomics; D009822:Oils, Volatile / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D010938:Plant Oils / Q000032:analysis* / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014556:Urine / Q000737:chemistry*
chemical_list: D004365:Drugs, Chinese Herbal; D009822:Oils, Volatile; D010938:Plant Oils